Senseonics Holdings (SENS) EBITDA Margin Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -283.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 72.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,505.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -184.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -3,846.00 |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn | -31,969.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31,969.00 |
| Dec 31, 2025 | -36,282.00 |
| Sep 30, 2025 | 106,738.00 |
| Jun 30, 2025 | -7.61 Mn |
| Mar 31, 2025 | -2.97 Mn |
| Dec 31, 2024 | -86,182.00 |
| Sep 30, 2024 | -1.61 Mn |
| Jun 30, 2024 | 4.12 Mn |
| Mar 31, 2024 | 839,334.00 |
| Dec 31, 2023 | 240,254.00 |
| Sep 30, 2023 | 266,017.00 |
| Jun 30, 2023 | 238,675.00 |
| Mar 31, 2023 | 13.74 Mn |
| Dec 31, 2022 | 61,438.00 |
| Sep 30, 2022 | -85,636.00 |
| Jun 30, 2022 | 7.65 Mn |
| Mar 31, 2022 | 3.03 Mn |
| Dec 31, 2021 | 77,676.00 |
| Sep 30, 2021 | 1.62 Mn |
| Jun 30, 2021 | -4.07 Mn |
| Mar 31, 2021 | -801,114.00 |
| Dec 31, 2020 | -205,654.00 |
| Sep 30, 2020 | -222,574.00 |
| Jun 30, 2020 | -135,916.00 |
| Mar 31, 2020 | -13.50 Mn |
| Dec 31, 2019 | 321,311.00 |
| Sep 30, 2019 | 2.90 Mn |
| Jun 30, 2019 | 6.18 Mn |
| Sep 30, 2018 | 2.20 Mn |
| Jun 30, 2018 | 2.91 Mn |
| Mar 31, 2018 | 3.52 Mn |